Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation-Reference-Cited by-同舟云学术

Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation

Published:2021-10-28 Issue:2 Volume:57 Page:282-285
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Martino Rodrigo^ORCID,García-Cadenas Irene^ORCID,Esquirol Albert^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01507-3.pdf

Reference17 articles.

1. Marco-Ayala J, Gómez-Seguí I, Sanz G, Solves P. Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question. Bone Marrow Transplant. 2021;56:769–78.

2. Longval T, Galimard JE, Leprêtre AC, Suarez F, Amiranoff D, Cazaux M, et al. Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study. Br J Haematol. 2021;193:814–26.

3. Booth GS, Savani BN, Langston AA. Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematopoietic cell transplantation. Br J Haematol. 2021;193:701–2.

4. Chapuy CI, Kaufman RM, Alyea EP, Connors JM. Daratumumab for delayed red-cell engraftment after allogeneic transplantation. N Engl J Med. 2018;379:1846–50.

5. Bathini S, Holtzman NG, Koka R, Singh Z, Wilding E, Zou Y, et al. Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab. Am J Hematol. 2019;94:E216–9.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aplastic anemia in association with multiple myeloma: clinical and pathophysiological insights;Leukemia & Lymphoma;2024-09-03

2. Seven-years post allogeneic hematopoietic stem cell transplantation pure red cell aplastic anemia cured with daratumumab: A case report and review of literature;World Journal of Clinical Cases;2024-08-26

3. Open-Label Phase 1/2 Study of Daratumumab-Based Desensitization Before Kidney Transplantation;Kidney International Reports;2024-08

4. Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review;Frontiers in Oncology;2024-07-02

5. Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data;Blood Advances;2024-03-28